Transparency practices at the FDA: A barrier to global health

Murray M. Lumpkin; Margaret A. Hamburg; William B. Schultz; Joshua M. Sharfstein

doi:10.1126/science.abq4981

Transparency practices at the FDA: A barrier to global health

Murray M. Lumpkin
, Margaret A. Hamburg
, William B. Schultz
, Joshua M. Sharfstein

Bloomberg School of Public Health

Research output: Contribution to journal › Article › peer-review

Abstract

Data sharing among regulators must be "business as usual".

Original language	English (US)
Pages (from-to)	572-574
Number of pages	3
Journal	Science
Volume	377
Issue number	6606
DOIs	https://doi.org/10.1126/science.abq4981
State	Published - Aug 5 2022

ASJC Scopus subject areas

General

Access to Document

10.1126/science.abq4981

Cite this

@article{2f41e21bf1a048c2b072cf2ccb9f9bfc,

title = "Transparency practices at the FDA: A barrier to global health",

abstract = "Data sharing among regulators must be {"}business as usual{"}.",

author = "Lumpkin, \{Murray M.\} and Hamburg, \{Margaret A.\} and Schultz, \{William B.\} and Sharfstein, \{Joshua M.\}",

note = "Funding Information: M.M.L. is a former deputy commissioner for international and special programs of FDA. M.A.H. is a former commissioner of FDA. W.B.S. is a former deputy commissioner for policy of FDA and former general counsel of the US Department of Health and Human Services. J.M.S. is a former principal deputy commissioner of FDA.",

year = "2022",

month = aug,

day = "5",

doi = "10.1126/science.abq4981",

language = "English (US)",

volume = "377",

pages = "572--574",

journal = "Science",

issn = "0036-8075",

publisher = "American Association for the Advancement of Science",

number = "6606",

}

TY - JOUR

T1 - Transparency practices at the FDA

T2 - A barrier to global health

AU - Lumpkin, Murray M.

AU - Hamburg, Margaret A.

AU - Schultz, William B.

AU - Sharfstein, Joshua M.

N1 - Funding Information: M.M.L. is a former deputy commissioner for international and special programs of FDA. M.A.H. is a former commissioner of FDA. W.B.S. is a former deputy commissioner for policy of FDA and former general counsel of the US Department of Health and Human Services. J.M.S. is a former principal deputy commissioner of FDA.

PY - 2022/8/5

Y1 - 2022/8/5

N2 - Data sharing among regulators must be "business as usual".

AB - Data sharing among regulators must be "business as usual".

UR - https://www.scopus.com/pages/publications/85135426438

UR - https://www.scopus.com/pages/publications/85135426438#tab=citedBy

U2 - 10.1126/science.abq4981

DO - 10.1126/science.abq4981

M3 - Article

C2 - 35926052

AN - SCOPUS:85135426438

SN - 0036-8075

VL - 377

SP - 572

EP - 574

JO - Science

JF - Science

IS - 6606

ER -

Transparency practices at the FDA: A barrier to global health

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this